Patents by Inventor Michael A. Barry

Michael A. Barry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12258572
    Abstract: This document provides adenovirus vectors and methods and materials related to using adenovirus vectors. For example, adenoviruses for delivering nucleic acid encoding one or more immunogens (e.g., one or more immunogens associated with a pathogen causing an infection) to cells within a mammal such that the mammal produces an effective immune response against the immunogen(s) are provided.
    Type: Grant
    Filed: September 8, 2021
    Date of Patent: March 25, 2025
    Assignee: Mayo Foundation for Medical Education and Research
    Inventor: Michael A. Barry
  • Publication number: 20250037473
    Abstract: Systems and methods for traffic measurement are disclosed. An image capture device is configured to generate image data including an area of interest within a physical environment containing at least one engagement feature. The image data is received and model input image data including a plurality of cropped images is generated by applying a zoom-in crop process to the image data. An image processing model generates a person count and dwell time. The image processing model receives the model input image data as an input. An engagement metric is generated based on the person count and the dwell time. The engagement metric is representative of engagement with the at least one engagement feature.
    Type: Application
    Filed: July 24, 2023
    Publication date: January 30, 2025
    Inventors: Jaley Himmatbhai Dholakiya, Rajesh Shreedhar Bhat, Shuchi Sureka, Edward Marc Welsh, Satpalsingh Jaspalsingh Ghunia, Sicheng Wang, Rajat Gupta, Naveen Selvam Ravichandran, Ziyi Tang, David Michael Barry, Harsha Raja Shivakumar, Xingming Qu, Xian Wang, Chaitanya Kumar Seri, Andrew Wesley Minteer, Andrew Jonathan Stevens
  • Publication number: 20250027058
    Abstract: This invention relates to methods and materials for nucleic acid delivery, vaccination, and/or treating cancer. More specifically, methods and materials for nucleic acid delivery, vaccination, and/or treating cancer using one or more recombinant adenoviruses (Ads) as an oncolytic agent are provided.
    Type: Application
    Filed: October 3, 2024
    Publication date: January 23, 2025
    Inventor: Michael A. BARRY
  • Patent number: 12139726
    Abstract: This invention relates to methods and materials for nucleic acid delivery, vaccination, and/or treating cancer. More specifically, methods and materials for nucleic acid delivery, vaccination, and/or treating cancer using one or more recombinant adenoviruses (Ads) as an oncolytic agent are provided.
    Type: Grant
    Filed: July 18, 2023
    Date of Patent: November 12, 2024
    Assignee: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventor: Michael A. Barry
  • Publication number: 20240333830
    Abstract: Disclosed herein are system, method, and computer program product embodiments for providing a mobile video conferencing interface with chat channel selection and file sharing integration. The video conferencing application also integrates with a chat messaging platform to provide streamlined access to multiple chat panels while still on a mobile device. A mobile device graphical user interface may include a video conference stream and access to a list of chat channels. The interface may allow a user to select a particular chat channel. In response to the selection, a messaging system retrieves messages corresponding to the chat channel and generates a chat panel. The chat panel is displayed along with the video conference stream. This interface is well-suited for mobile screens. The interface also allows for file sharing between chat panels displayed on the mobile device.
    Type: Application
    Filed: March 29, 2024
    Publication date: October 3, 2024
    Applicant: WORKSTORM.COM LLC
    Inventors: Raj FERNANDO, Anatoliy YUDOVICH, Michael BARRY, Andrew CHRISTENSEN, Nicholas STECH
  • Publication number: 20240325570
    Abstract: This document relates to methods and materials for treating a mammal (e.g., a human) having, or at risk of developing, a polycystic disease (e.g., a polycystic kidney disease (PKD)). For example, methods and materials that can be used to increase a level of polycystin-1 (PC-1) polypeptides and/or polycystin-2 (PC-2) polypeptides within a mammal having, or at risk of developing, a polycystic disease) are provided. In some cases, nucleic acid designed to increase a level of PC-1 polypeptides and/or PC-2 polypeptides within a mammal can be administered to a mammal having, or at risk of developing, a polycystic disease to treat the mammal.
    Type: Application
    Filed: January 14, 2022
    Publication date: October 3, 2024
    Inventors: Michael A. Barry, Christopher Y. Chen, Jeffrey D. Rubin, Vincente E. Torres
  • Patent number: 12060582
    Abstract: This invention relates to methods and materials for nucleic acid delivery, vaccination, and/or treating cancer. More specifically, methods and materials for nucleic acid delivery, vaccination, and/or treating cancer using one or more recombinant adenoviruses (Ads) as an oncolytic agent are provided.
    Type: Grant
    Filed: July 17, 2023
    Date of Patent: August 13, 2024
    Assignee: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventor: Michael A. Barry
  • Publication number: 20240257064
    Abstract: Disclosed herein are system, method, and computer program product embodiments for integrating external contacts, events, and cloud storage systems with a messaging system. The messaging system may interface with one or more events systems and/or cloud storage systems while facilitating the delivery of messages. These may include chat and/or instant messages. Via application programming interface (API) calls to the events systems, the messaging system may retrieve contact information for generating calendar events. The messaging system may instruct the events system to generate an event and/or send invitations to the event. The messaging system may also instruct the events systems to invite contacts to a video conference. Via API calls to the cloud storage systems, the messaging system may access files stored by the cloud storage systems. The messaging system may share the files between users using chat panels and/or update file permissions on the cloud storage systems.
    Type: Application
    Filed: January 26, 2023
    Publication date: August 1, 2024
    Inventors: Raj FERNANDO, Anatoliy YUDOVICH, Michael BARRY, Andrew CHRISTENSEN
  • Publication number: 20240175050
    Abstract: Methods and materials for treating propionic acidemia are provided herein. For example, methods and materials for using AAVs to express a PCCA polypeptide and/or a PCCB polypeptide within a mammal to treat propionic acidemia are provided.
    Type: Application
    Filed: March 18, 2022
    Publication date: May 30, 2024
    Inventor: Michael A. Barry
  • Publication number: 20240157105
    Abstract: Methods of tattooing and tattoo inking systems comprising a housing, an ink reservoir, a pump and a tattoo cartridge. According to a further embodiment the tattoo inking system comprises a system of channels and valves that allow the artist to provide ink to the tattoo cartridge while working and without dipping.
    Type: Application
    Filed: November 10, 2023
    Publication date: May 16, 2024
    Inventor: Scott Michael BARRY
  • Publication number: 20240070481
    Abstract: Various embodiments are provided for configuring optimization problems from one or more sources in a computing environment by a processor. A knowledge graph may be generated from a knowledge domain and one or more data sources. One or more graph pattens may be applied to match one or more entities in the knowledge graph with one or more atomic optimization templates. An optimization problem configured from the one or more atomic optimization templates and a plurality of data may be executed.
    Type: Application
    Filed: August 26, 2022
    Publication date: February 29, 2024
    Applicant: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Michael BARRY, Joern PLOENNIGS, John SHEEHAN, Claudio GAMBELLA
  • Publication number: 20240026307
    Abstract: This invention relates to methods and materials for nucleic acid delivery, vaccination, and/or treating cancer. More specifically, methods and materials for nucleic acid delivery, vaccination, and/or treating cancer using one or more recombinant adenoviruses (Ads) as an oncolytic agent are provided.
    Type: Application
    Filed: July 17, 2023
    Publication date: January 25, 2024
    Inventor: Michael A. BARRY
  • Publication number: 20240018546
    Abstract: This document relates to adenovirus vectors and methods and materials related to using adenovirus vectors. For example, viruses, nucleic acid molecules encoding viruses, cell lines containing viral vectors, and methods for using viruses to deliver nucleic acid to cells in vitro or in vivo are provided. Methods and materials for using adenovirus vectors to induce immune responses and to treat cancer also are provided.
    Type: Application
    Filed: September 15, 2023
    Publication date: January 18, 2024
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Michael A. Barry, Eric Weaver
  • Publication number: 20230365943
    Abstract: This invention relates to methods and materials for nucleic acid delivery, vaccination, and/or treating cancer. More specifically, methods and materials for nucleic acid delivery, vaccination, and/or treating cancer using one or more recombinant adenoviruses (Ads) as an oncolytic agent are provided.
    Type: Application
    Filed: July 18, 2023
    Publication date: November 16, 2023
    Inventor: Michael A. BARRY
  • Patent number: 11795477
    Abstract: This document relates to adenovirus vectors and methods and materials related to using adenovirus vectors. For example, viruses, nucleic acid molecules encoding viruses, cell lines containing viral vectors, and methods for using viruses to deliver nucleic acid to cells in vitro or in vivo are provided. Methods and materials for using adenovirus vectors to induce immune responses and to treat cancer also are provided.
    Type: Grant
    Filed: February 14, 2022
    Date of Patent: October 24, 2023
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Michael A. Barry, Eric Weaver
  • Patent number: 11796382
    Abstract: An apparatus for sensing acoustic energy in a borehole penetrating the earth includes an optical interrogator and a sensing optical fiber having a length Ls optically coupled to the optical interrogator and configured to sense the acoustic energy to provide sensed acoustic data. The apparatus also includes a reference optical fiber having a length Lr optically coupled to the optical interrogator to provide reference data, wherein the optical interrogator corrects the sensed acoustic data using the reference data to provide corrected sensed acoustic data.
    Type: Grant
    Filed: November 21, 2019
    Date of Patent: October 24, 2023
    Assignee: BAKER HUGHES OILFIELD OPERATIONS LLC
    Inventors: William Albert Johnston, Alexander Michael Barry
  • Publication number: 20230279428
    Abstract: This document provides adenovirus vectors and methods and materials related to using adenovirus vectors. For example, adenoviruses for delivering nucleic acid encoding one or more immunogens (e.g., one or more immunogens associated with a pathogen causing an infection) to cells within a mammal such that the mammal produces an effective immune response against the immunogen(s) are provided.
    Type: Application
    Filed: August 17, 2021
    Publication date: September 7, 2023
    Inventor: Michael A. Barry
  • Patent number: 11746334
    Abstract: This invention relates to methods and materials for nucleic acid delivery, vaccination, and/or treating cancer. More specifically, methods and materials for nucleic acid delivery, vaccination, and/or treating cancer using one or more recombinant adenoviruses (Ads) as an oncolytic agent are provided.
    Type: Grant
    Filed: November 21, 2019
    Date of Patent: September 5, 2023
    Assignee: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventor: Michael A. Barry
  • Patent number: 11678347
    Abstract: A method may be provided. One or more packets from a client may be received, in a block based modulation environment, at one or more switchable antennas of an access point. The access point may have a plurality of switchable antennas. Each switchable antenna may have an antenna state. The plurality of switchable antennas may be switched among such that at least five of the antenna states are sampled. Angle of arrival of the client may be calculated based on the at least five of the antenna states.
    Type: Grant
    Filed: January 8, 2021
    Date of Patent: June 13, 2023
    Assignee: Cisco Technology, Inc.
    Inventors: Matthew Aaron Silverman, Ardalan Alizadeh, Michael Barry DeLong, Guru Prasanna Gopalakrishnan
  • Patent number: 11485767
    Abstract: This invention provides methods and materials for treating cancer. The invention encompasses methods and materials for delivering programmed death-ligand 1 (PD-L1) binding compounds and/or compositions containing one or more monovalent or multivalent programmed death-ligand 1 (PD-L1) binding compounds which are administered to a mammal having cancer to treat the mammal. In some cases, a multivalent PD-L1 binding compound can include two or more programmed cell death protein 1 (PD-1) polypeptides (and/or fragments thereof having the ability to bind PD-L1). This invention also provides methods and materials for making multivalent PD-L1 binding compounds and methods and materials for making nucleic acid molecules that encode PD-L1 binding compounds.
    Type: Grant
    Filed: April 28, 2020
    Date of Patent: November 1, 2022
    Assignee: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventor: Michael A. Barry